Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease

Pediatric Allergy and Immunology

Volumn 20, Issue 3, 2009, Pages 266-272

  Kuo, Ho Chang ^a,b,c   Wang, Chih Lu ^d   Liang, Chi Di ^a   Yu, Hong Ren ^a,b,c   Huang, Chien Fu ^a   Wang, Lin ^a,b,c   Hwang, Kao Pin ^a   Yang, Kuender D ^a,b,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Division of Allergy Immunology and Rheumatology   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d Po Jen Hospital   (Taiwan)

Author keywords

Coronary artery lesions; Eosinophil cationic protein; Eosinophils; Interleukin 5; Kawasaki disease; T helper 2

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; IMMUNOGLOBULIN; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EOSINOPHILIA; FEMALE; FLUOROIMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATIENT ASSESSMENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; TH2 CELL;

ADOLESCENT; BLOOD CELL COUNT; CORONARY ARTERY DISEASE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TH2 CELLS; YOUNG ADULT;

EID: 65449170070     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2008.00779.x     Document Type: Article

References (35)

1. Kawasaki T, Kosaki F, Osawa S, Shigemitsu I, Yanagawa S. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974 : 54 : 271 6.
2. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 2005 : 24 : 998 1004.
3. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004 : 364 : 533 44.
4. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004 : 110 : 2747 71.
5. Hsu YH, Wang YH, Hsu WY, Lee YP. Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guerin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987 : 6 : 576 8.
6. Newburger JW, Takahashi M, Beiser AS, et al. A single infusion of intravenous gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991 : 324 : 1633 9.
7. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986 : 315 : 341 7.
8. Terai M, Yasukawa K, Honda T, et al. Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J 2002 : 21 : 777 81.
9. Kuo HC, Yang KD, Liang CD, et al. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 2007 : 18 : 354 9.
10. Kuo HC, Wang CL, Wang L, Yu HR, Yang KD. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease. Pediatr Allergy Immunol 2008 : 19 : 184 5.
11. Akagi T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 1992 : 121 : 689 94.
12. Shulman ST, Inocencio J, Hirsch R. Kawasaki disease. Pediatr Clin North Am 1995 : 42 : 1205 22.
13. Pickering JW, Martins TB, Schroder MC, Hill HR. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Clin Diagn Lab Immunol 2002 : 9 : 872 6.
14. Baba R, Shibata A, Tsurusawa M. Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity. Circ J 2005 : 69 : 962 4.
15. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease. J Pediatr 2000 : 137 : 177 80.
16. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and re-treatment in Kawasaki disease. Pediatr Infect Dis J 1998 : 17 : 1144 8.
17. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 1998 : 81 : 1116 20.
18. Kim T, Choi W, Woo CW, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 2007 : 11 : 166 : 421 5.
19. Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int 2005 : 47 : 305 10.
20. Hamamichi Y, Ichida F, Yu X, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res 2001 : 49 : 74 80.
21. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 2003 : 24 : 122 6.
22. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observations of 50 cases (In Japanese). Arerugi 1967 : 16 : 178 222.
23. Kuo HC, Wang CL, Ligan CD, et al. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. J Microbiol Immunol Infect 2007 : 40 : 395 400.
24. Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DY. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J 1988 : 7 : 863 6.
25. Furukawa S, Matsubara T, Motohashi T, et al. Increased expression of Fc epsilon R2-CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease. Int Arch Allergy Appl Immunol 1991 : 95 : 7 12.
26. Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997 : 112 : 152 6.
27. Matsubara T, Katayama K, Matsuoka T, Fujiwara M, Koga M, Furukawa S. Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol 1999 : 116 : 554 7.
28. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003 : 111 : 291 7.
29. Mosmann TR, Coffman RL. Th1 and Th2 cells, different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989 : 7 : 145 73.
30. Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Kawase H, Sekine I. Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 2000 : 119 : 376 81.
31. Okada Y, Shinohara M, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 2003 : 143 : 363 7.
32. Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 2005 : 174 : 5837 45.
33. Mazzolai L, Duchosal MA, Korber M, et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE--- mice. Hypertension 2004 : 44 : 277 82.
34. Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Clin Exp Dermatol 2005 : 30 : 61 3.
35. Suzuki N, Nara K, Suzuki T. Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease. Clin Med Res 2006 : 4 : 147 51.